By using an RNAi-mediated loss-of-function screening approach, we have identified CSNK1E, a member of the casein kinase family, as an essential regulator of β-catenin activity and proliferation in breast cancer cell lines. The gene discussed is CSNK1E; the disease is breast carcinoma.